Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital

被引:9
|
作者
Zhang, Di [1 ]
Cui, Kai [2 ]
Wang, Taotao [1 ]
Shan, Yuanyuan [1 ]
Dong, Haiyan [1 ]
Feng, Weiyi [1 ]
Ma, Chen [1 ,3 ]
Dong, Yalin [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Pharm, Yanta West Rd 277, Xian 710061, Shaanxi, Peoples R China
[2] Xian Univ Posts & Telecommun, Dept Management Econ, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Clin Lab, Xian, Shaanxi, Peoples R China
来源
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2018年 / 12卷 / 08期
关键词
Pseudomonas aeruginosa; carbapenem resistantance; risk factors; mortality; ANTIMICROBIAL RESISTANCE; BACTEREMIA; ENTEROBACTERIACEAE; SELECTION;
D O I
10.3855/jidc.10150
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is rapidly emerging as a life-threatening nosocomial infection. In this study, we aimed to identify risk factors, especially antibiotic use and co-carriage with other bacteria for CRPA infection or colonization. Methodology: A retrospective study was conducted in the First Affiliated Hospital of Xi'an Jiaotong University, which involved a cohort of patients with Pseudomonas aeruginosa infection or colonization from January 2014 to June 2016. Univariate analysis and multivariate analysis were performed to estimate the risk factors of CRPA occurrence. Results: Eight hundred and eighty-eight patients were included in the study. More than 50% of the risk factors were associated with CRPA infection or colonization according to univariate analysis (P < 0.05), such as invasive procedures, co-carriage with Gram-negative pathogens, and prior treatment with some antibiotics. However, only prior exposure to carbapenems (OR: 8.005; CI: 4.507-14.217, P < 0.001), the days of carbapenems treatment (OR: 1.190; CI: 1.073-1.272; P < 0.001), and co-carriage with Escherichia coli (OR: 1.824; CI: 1.005-3.310, P = 0.048) were considered independent risk factors by multivariate analysis. A higher mortality was found among patients with CRPA infection or colonization (P < 0.05). Conclusions: Risk factors for CRPA infection or colonization were prior exposure to carbapenems, the days of carbapenems treatment, and co-carriage with Escherichia coli. The prevalence of CRPA could be influenced by Gram-negative pathogens, especially in Escherichia coli, and it need more researches. Moreover, restrictions in the clinical use of carbapenems should be taken into account.
引用
收藏
页码:642 / 648
页数:7
相关论文
共 50 条
  • [41] Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection
    Kim, Y. J.
    Kim, S. I.
    Kim, Y. R.
    Hong, K. W.
    Wie, S. H.
    Park, Y. J.
    Jeong, H.
    Kang, M. W.
    EPIDEMIOLOGY AND INFECTION, 2012, 140 (01) : 137 - 145
  • [42] Carbapenem-resistant Pseudomonas aeruginosa infections in critically ill children: Prevalence, risk factors, and impact on outcome in a large tertiary pediatric hospital of China
    Huang, Weichun
    Wei, Xiaoshu
    Xu, Guifeng
    Zhang, Xingyu
    Wang, Xing
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [43] An analysis of risk factors for carbapenem-resistant Enterobacteriaceae infection
    Gao, Yan
    Chen, Meilian
    Cai, Meng
    Liu, Kun
    Wang, Yimin
    Zhou, Chunlian
    Chang, Zhigang
    Zou, Qi
    Xiao, Shirou
    Cao, Yang
    Wang, Weihua
    Liu, Zhuang
    Lv, Linfang
    Luo, Yajun
    Wu, Yinghong
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 30 : 191 - 198
  • [44] Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital
    Li, Chen
    Li, Yi
    Zhao, Zhichang
    Liu, Qing
    Li, Bin
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2019, 12 (01) : 26 - 31
  • [45] Clinical and Economic Burden of Carbapenem-Resistant Infection or Colonization Caused byKlebsiella pneumoniae,Pseudomonas aeruginosa,Acinetobacter baumannii: A Multicenter Study in China
    Zhen, Xuemei
    Lundborg, Cecilia Stalsby
    Sun, Xueshan
    Gu, Shuyan
    Dong, Hengjin
    ANTIBIOTICS-BASEL, 2020, 9 (08): : 1 - 13
  • [46] "Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa
    Marchaim, Dror
    Perez, Federico
    Lee, Jiha
    Bheemreddy, Suchitha
    Hujer, Andrea M.
    Rudin, Susan
    Hayakawa, Kayoko
    Lephart, Paul R.
    Blunden, Christopher
    Shango, Maryann
    Campbell, Michelle L.
    Varkey, Jastin
    Manickam, Palaniappan
    Patel, Diixa
    Pogue, Jason M.
    Chopra, Teena
    Martin, Emily T.
    Dhar, Sorabh
    Bonomo, Robert A.
    Kaye, Keith S.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2012, 40 (09) : 830 - 835
  • [47] Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome
    Jeong, Su Jin
    Yoon, Sang Sun
    Bae, Il Kwon
    Jeong, Seok Hoon
    Kim, June Myung
    Lee, Kyungwon
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2014, 80 (02) : 130 - 135
  • [48] Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital
    Zhang, Na
    Qi, Lihua
    Liu, Xiong
    Jin, Meiling
    Jin, Yuan
    Yang, Xiaojing
    Chen, Jiali
    Qin, Shiyu
    Liu, Fangni
    Tang, Yue
    Jia, Ruizhong
    Zhang, Xiushan
    Wang, Yong
    Guo, Jinpeng
    Liu, Jie
    Wang, Changjun
    Chen, Yong
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [49] Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital
    Xiujuan Meng
    Sidi Liu
    Juping Duan
    Xun Huang
    Pengcheng Zhou
    Xinrui Xiong
    Ruie Gong
    Ying Zhang
    Yao Liu
    Chenchao Fu
    Chunhui Li
    Anhua Wu
    BMC Infectious Diseases, 17
  • [50] An 11-year experience of carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa bacteremia
    Cho, E.
    Choi, S. -H.
    Chung, J. -W.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S98 - S98